TMA blocks were created using CRC specimens obtained from a total of 421 primary CRC patients (181 female, 240 male) for analyses including PD-1, PD-L1, CD-3, CD-8, and CD45RO expression on ICs. This evidence concerns the gene CD8A and colorectal carcinoma.